Clinical trial
Direct-acting Antiviral Therapy and Reinfection Among People With Chronic Hepatitis C Virus Infection and Recent Injecting Drug Use in Community-based Settings: the SHARP-C Study
NCT03343925 is registered in ClinicalTrials.gov with Kirby Institute as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Direct-acting Antiviral Therapy and Reinfection Among People With Chronic Hepatitis C Virus Infection and Recent Injecting Drug Use in Community-based Settings: the SHARP-C Study
- Lead sponsor
- Kirby Institute
- Phase
- Observational
- Overall status
- Completed
- Start date
- August 17, 2018
- Completion date
- April 11, 2022
- Enrollment
- 140 (actual)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.